Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Enrique Neumann, Beckman Coulter Diagnostics, on Automation Solutions
In the video, Enrique Neumann, the Field Marketing Manager of Genomics from Beckman Coulter Diagnostics, […]
Matthew Crowther, Beckman Coulter Diagnostics, on Emerging Resistance
In this video, Matthew Crowther, the Northern Europe Sales Manager at Beckman Coulter Diagnostics, discusses […]
Keegan Nees, IMMY, on Fungal Infection Diagnostics
We caught up with Keegan Nees, a Product Marketing Strategist from IMMY, at ECCMID, who discusses […]
Dwaine Vance, Randox, on Molecular Diagnostics
At ECCMID, we caught up with Dwaine Vance from Randox, who discusses his company’s contribution […]
Michael Corley, BSAC, on Partnerships Within the Antibiotic Community
In the video, Michael Corley, the Head of Policy & Public Affairs at the British […]
Dr. Jacqueline Sneddon, BSAC, on Antibiotics
At the 33rd ECCMID event, we caught up with Dr. Jacqueline Sneddon, the Programmes Manager […]
Nelson Fernandes, CerTest Biotec, on Diagnostic Products
We caught up with Nelson Fernandes, the Managing Director at CerTest Biotec, at 33rd ECCMID […]
Katerina Evangeli, Pro-Lab Diagnostics, on New Diagnostic Products and Technologies
In this interview, Katerina Evangeli, Territory Manager at Pro-Lab Diagnostics, discussed her company’s new Diagnostic […]
MTA's ECCMID 2023 Highlight Reel
The 33rd ECCMID (European Congress of Clinical Microbiology and Infectious Diseases) is a scientific conference […]
ECCMID 2023: Shionogi to Present Data Showing COVID-19 Symptom Recurrence is Not Associated with Ensitrelvir Treatment
Shionogi today announced that two late-breaking poster presentations featuring new results from the Phase 3 […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more